NVR YL7 Pill - pink oval, 16mm
Generic Name: alpelisib
Pill with imprint NVR YL7 is Pink, Oval and has been identified as Piqray 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Piqray is used in the treatment of Breast Cancer; Breast Cancer, Male and belongs to the drug class PI3K inhibitors. Piqray 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR YL7
Piqray
- Generic Name
- alpelisib
- Imprint
- NVR YL7
- Strength
- 200 mg
- Color
- Pink
- Size
- 16.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- PI3K inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0701
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
More about Piqray (alpelisib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.